StarZero All shows Try the podcast clipper →

oncology

2 statements across 2 episodes · 1 bullish · 0 bearish · 2 people on the record · first statement Jan 14, 2019 by Jean Hynes · across every show →

Everything said about oncology, oldest first

Jan 14, 2019 neutral
Assertion Supported
Hynes: Roughly 40% of biopharma R&D is allocated to oncology
“About 40% of the Industries of R&D now is going to oncology.”
Jean Hynes Jan 14, 2019 ▶ 13:22 Jean Hynes – Inside Wellington Management (Capital Allocators, EP.82)
Jun 1, 2020 positive
Assertion Not checkable as stated
Futch says US drug pricing headwinds spare only oncology and orphan diseases
“Pricing headwinds in the U.S. That really applies to almost all therapeutic categories other than Orphan and oncology.”
Clark Futch Jun 1, 2020 ▶ 46:39 Clarke Futch – Healthcare Royalty Partners (First Meeting, EP.20)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 700 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more